Clinical Trials Browser

Phase 2 × Has results × vatalanib × Clear all

Hemangiopericytoma, Malignant, Brain Neoplasms, Meningioma, Sarcoma, Central Nervous System Neoplasms

NCT00072475 2016-08-01

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases

NCT00240162 2014-09-17

PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma

Phase 2 Terminated

21 enrolled 11 charts

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Clinical Trials

Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma